S. C. Oğlak Et Al. , "The reduced serum concentrations of β-arrestin-1 and β-arrestin-2 in pregnancies complicated with gestational diabetes mellitus," Journal of Maternal-Fetal and Neonatal Medicine , vol.35, no.25, pp.10017-10024, 2022
Oğlak, S. C. Et Al. 2022. The reduced serum concentrations of β-arrestin-1 and β-arrestin-2 in pregnancies complicated with gestational diabetes mellitus. Journal of Maternal-Fetal and Neonatal Medicine , vol.35, no.25 , 10017-10024.
Oğlak, S. C., Yavuz, A., Olmez, F., Gedik Özköse, Z., & Süzen Çaypınar, S., (2022). The reduced serum concentrations of β-arrestin-1 and β-arrestin-2 in pregnancies complicated with gestational diabetes mellitus. Journal of Maternal-Fetal and Neonatal Medicine , vol.35, no.25, 10017-10024.
Oğlak, Süleyman Et Al. "The reduced serum concentrations of β-arrestin-1 and β-arrestin-2 in pregnancies complicated with gestational diabetes mellitus," Journal of Maternal-Fetal and Neonatal Medicine , vol.35, no.25, 10017-10024, 2022
Oğlak, Süleyman C. Et Al. "The reduced serum concentrations of β-arrestin-1 and β-arrestin-2 in pregnancies complicated with gestational diabetes mellitus." Journal of Maternal-Fetal and Neonatal Medicine , vol.35, no.25, pp.10017-10024, 2022
Oğlak, S. C. Et Al. (2022) . "The reduced serum concentrations of β-arrestin-1 and β-arrestin-2 in pregnancies complicated with gestational diabetes mellitus." Journal of Maternal-Fetal and Neonatal Medicine , vol.35, no.25, pp.10017-10024.
@article{article, author={Süleyman Cemil Oğlak Et Al. }, title={The reduced serum concentrations of β-arrestin-1 and β-arrestin-2 in pregnancies complicated with gestational diabetes mellitus}, journal={Journal of Maternal-Fetal and Neonatal Medicine}, year=2022, pages={10017-10024} }